Monday - May 12, 2025

Category Archives: Marketing & Sales

Dupuytren’s Disease Market Statistics Expected to Experience Major Growth by 2034, According to DelveInsight | Endo Pharma, Asahi Kasei Pharma, 180 Life Sciences, Ventoux Biosciences

  DelveInsight’s “Dupuytren’s Disease Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Dupuytren’s Disease, historical and forecasted epidemiology as well as the Dupuytren’s Disease market trends in the United States, EU4 (Germany, Spain, Italy, France) … Continue reading →

Patient Monitoring Devices Market Projected to Reach ~USD 56 Billion by 2030, Driven by Advanced AI Integration and Recent FDA Clearances | DelveInsight

Patient Monitoring Devices – Market Insight, Competitive Landscape, and Market Forecast, 2030 The patient monitoring devices market is poised for substantial growth, driven by the rising prevalence of chronic diseases and increasing preference for remote healthcare solutions. The market is … Continue reading →

Where is Natural Ergothioneine derived from? Specifications and Industry Applications

1. Microbial Biosynthesis: The Primary OriginErgothioneine is predominantly synthesized by microorganisms, including fungi, bacteria, and cyanobacteria. Its biosynthesis pathway involves the condensation of L-histidine and L-cysteine, catalyzed by specific enzymes such as EgtB and EgtA . For example: Fungi: Mushrooms, … Continue reading →

Andersen-Tawil Syndrome Market Set for Notable Growth Through 2032 Amid Advances in Genetic Diagnostics and Targeted Therapies | DelveInsight

Andersen-Tawil Syndrome Market Insights, Epidemiology, and Market Forecast – 2032 The Andersen-Tawil Syndrome market is poised for steady growth, with rising disease awareness, improved diagnostic capabilities, and emerging therapeutic options addressing the underlying genetic mutations and the severe symptomatic manifestations … Continue reading →

Retinal Edema Market Expected to Witness Significant Growth Through 2032, Driven by Recent FDA Approvals and a Robust Clinical Pipeline | DelveInsight

Retinal Edema – Market Insight, Epidemiology And Market Forecast – 2032 The retinal edema market is witnessing significant growth, primarily fueled by the increasing prevalence of conditions associated with retinal edema, particularly diabetic macular edema, and a robust pipeline of … Continue reading →

Allergic Contact Dermatitis Market Poised for Expansion Through 2032, Driven by Recent FDA Approvals and Emerging Therapies Targeting Specific Immune Pathways | DelveInsight

Allergic Contact Dermatitis – Market Insight, Epidemiology And Market Forecast – 2032 The allergic contact dermatitis treatment market is poised for substantial growth, driven by increasing prevalence rates, growing awareness, enhanced diagnostic capabilities, and the emergence of innovative treatment options … Continue reading →

Kernicterus Treatment Market to Witness Significant Growth, Driven by Increased Awareness and Expanded Research Funding | DelveInsight

Kernicterus – Market Insight, Epidemiology And Market Forecast – 2032 The kernicterus treatment market is experiencing notable growth, reflecting an increasing awareness about neonatal jaundice complications, advancements in diagnostic technologies, and innovative therapies by key kernicterus companies, including Mylan N.V., … Continue reading →

Aortic Stenosis Market Set for Significant Expansion by 2032, Boosted by Technological Advancements and FDA Nod for Edwards TAVR in Asymptomatic Cases | DelveInsight

Aortic Stenosis Market The Aortic Stenosis market is progressing steadily, driven by the increasing prevalence of the disease, advancements in minimally invasive therapies, and growing adoption of transcatheter aortic valve replacement (TAVR). In a pivotal regulatory milestone, Edwards Lifesciences has … Continue reading →

Defibrillators Market Accelerates with FDA Nod to Element Science’s Jewel® Patch-WCD, Ushering in a New Era of Wearable Cardiac Care | DelveInsight

Defibrillators Market The defibrillators market is witnessing robust growth driven by the rising prevalence of cardiac arrhythmias, greater awareness of early defibrillation, and the increasing use of AEDs in public spaces. Technological advancements in wearable and implantable devices, along with … Continue reading →

Relapsed/Refractory Multiple Myeloma Market Poised for Remarkable Growth by 2032, Driven by Innovation and FDA Fast Track Designation for Ichnos Glenmark’s ISB 2001 | DelveInsight

Relapsed/Refractory Multiple Myeloma Market The Relapsed/Refractory Multiple Myeloma market is evolving rapidly, propelled by new treatment options, advancements in research, and regulatory support. In a significant development, Ichnos Glenmark Innovation (IGI) has received FDA Fast Track Designation for its investigational … Continue reading →